Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of drugs targeting central nervous system disorders and anti-inflammatory agents. This compound, tert-butyl (cis-4-hydroxycyclohexyl)(methyl)carbamate, features a cis configuration with a 4-hydroxycyclohexyl ring attached to an N-methylcarbamate group protected by tert-butyl. The protecting group enables selective reactions by shielding the nitrogen, with deprotection possible in final synthesis steps. Its functional groups, including the protected amine and alcohol, facilitate further modifications for bioactive molecules. Commonly employed in medicinal chemistry as a building block for peptidomimetics, receptor modulators, protease inhibitors, and other therapeutic agents requiring stereochemical control.